Estrella Immunopharma, Inc. (ESLA, ESLAW)

CIK 1844417 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Estrella Immunopharma, Inc..

Recent SEC filings

FiledFormAccession number
Sep 8, 20268-K0001213900-26-098123
Aug 26, 202640001996255-26-000004
Aug 25, 202640001213900-26-093698
Aug 21, 20268-K0001213900-26-092657
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003573
Aug 13, 202610-Q0001213900-26-089215
Jun 30, 20268-K0001213900-26-073847
May 27, 2026DEF 14A0001140361-26-023012
May 18, 2026NT 10-Q0001213900-26-058062
May 18, 202610-Q0001213900-26-058063
May 15, 2026SCHEDULE 13G0001172661-26-002144
Apr 30, 202610-K/A0001213900-26-050433
Apr 29, 202640001213900-26-049602
Mar 18, 202610-K0001213900-26-029357
Feb 13, 2026424B30001213900-26-016605
Jan 23, 2026EFFECT9999999995-26-000279
Jan 22, 2026S-1/A0001213900-26-006410
Jan 16, 2026S-1/A0001213900-26-005233
Jan 13, 20268-K0001213900-26-003998
Jan 6, 20268-K0001213900-26-001777
Jan 6, 2026424B50001213900-26-001686
Dec 22, 2025S-10001213900-25-124247
Dec 4, 20258-K0001213900-25-118097
Nov 6, 20258-K0001213900-25-107249
Oct 1, 202530001213900-25-094562